Our data suggest that early upregulation of MDM2 is another possible mechanism by which AML1-ETO overcomes the p53 tumor suppressor pathway, and show that the MDM2 inhibitor nutlin-3 causes a specific inhibition of the proliferation and self-renewal of cells transformed by AML1-ETO. This evidence concerns the gene RUNX1T1 and neoplasm.